🎙️ “This isn’t red tape. It’s obstruction.”
— Duane Boise, CEO of MMJ International Holdings, on Cannabis Coast to Coast News (7/14/25)
🚨 In his explosive national interview, Duane Boise exposes the DEA’s ongoing sabotage of FDA-authorized medical cannabis research. Despite full regulatory compliance and millions invested in a pharmaceutical-grade facility, MMJ BioPharma has been blocked from launching its Huntington’s disease and MS trials—because the DEA refuses to issue a bulk manufacturing license.
🔥 Boise’s Highlights:
✅ “We followed every rule—but DEA weaponized the system against us.”
✅ “The DEA’s administrative process isn’t just broken—it’s unconstitutional.”
✅ “We’re filing a federal lawsuit to hold corrupt officials accountable and defend patient access.”
🧠MMJ’s mission: Advance pharmaceutical-grade cannabinoid drugs—not dispensary products—via FDA pathways, for diseases with no cure.
